Literature DB >> 21357803

The relationship between hospital spending and mortality in patients with sepsis.

Tara Lagu1, Michael B Rothberg, Brian H Nathanson, Penelope S Pekow, Jay S Steingrub, Peter K Lindenauer.   

Abstract

BACKGROUND: Sepsis is common, highly morbid, and costly, yet little is known about differences in the care or outcomes of patients with sepsis across hospitals. We sought to characterize variations in hospital spending and mortality rates and to determine whether higher levels of spending are associated with better hospital survival.
METHODS: We conducted a cross-sectional study of hospitals that treated at least 100 adult patients with sepsis between 2004 and 2006. We developed multivariable models for expected patient mortality and costs and calculated standardized mortality and cost ratios for each hospital. We defined clinically significant variation as observed outcomes that differed from expected outcomes by at least 10%. We examined the association between hospital-level spending and mortality rate using a model that adjusted for hospital characteristics.
RESULTS: Among 166,931 patients with sepsis at 309 hospitals, we observed wide variations in hospital-level mortality and cost. Of 61 hospitals (19%) at the median expected mortality, observed mortality ranged from 9% to 32%. More than a third (34%) of hospitals exceeded expected costs by at least 10%, with a median average excess cost of $5207. We found lower-than-expected costs and mortality rates at 22 hospitals (7%). An adjusted model did not show a significant association between hospital spending and mortality.
CONCLUSIONS: Hospital spending and adjusted mortality rates for patients with sepsis vary substantially, but higher hospital expenditures are not associated with better survival. Efforts to enhance the value of sepsis care could be modeled on hospitals that achieve lower-than-expected mortality and costs.

Entities:  

Mesh:

Year:  2011        PMID: 21357803     DOI: 10.1001/archinternmed.2011.12

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  Patterns of use of hemostatic agents in patients undergoing major surgery.

Authors:  Jason D Wright; Cande V Ananth; Sharyn N Lewin; William M Burke; Zainab Siddiq; Alfred I Neugut; Thomas J Herzog; Dawn L Hershman
Journal:  J Surg Res       Date:  2013-08-13       Impact factor: 2.192

2.  Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation.

Authors:  Inga Wessels; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-13       Impact factor: 4.052

3.  Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier.

Authors:  Shazia Bashir; Cande V Ananth; Sharyn N Lewin; William M Burke; Yu-Shiang Lu; Alfred I Neugut; Thomas J Herzog; Dawn L Hershman; Jason D Wright
Journal:  Dis Colon Rectum       Date:  2013-10       Impact factor: 4.585

4.  Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer.

Authors:  D L Hershman; C A Richards; K Kalinsky; E T Wilde; Y S Lu; J A Ascherman; A I Neugut; J D Wright
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

5.  Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures.

Authors:  Nicasio Mancini; Laura Infurnari; Nadia Ghidoli; Grazia Valzano; Nicola Clementi; Roberto Burioni; Massimo Clementi
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

Review 6.  The association between health care quality and cost: a systematic review.

Authors:  Peter S Hussey; Samuel Wertheimer; Ateev Mehrotra
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

Review 7.  Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis.

Authors:  Lin Ouyang; You-Di Lv; Can Hou; Guo-Bao Wu; Zhi-Hui He
Journal:  Mol Biol Rep       Date:  2013-05-29       Impact factor: 2.316

8.  Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis.

Authors:  Theodore J Iwashyna; Andrew Odden; Jeffrey Rohde; Catherine Bonham; Latoya Kuhn; Preeti Malani; Lena Chen; Scott Flanders
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

9.  Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients.

Authors:  Zhu Cui; Jason D Wright; Melissa K Accordino; Donna Buono; Alfred I Neugut; Jim C Hu; Dawn L Hershman
Journal:  Cancer Invest       Date:  2016-04-11       Impact factor: 2.176

10.  Variation in Physician Spending and Association With Patient Outcomes.

Authors:  Yusuke Tsugawa; Ashish K Jha; Joseph P Newhouse; Alan M Zaslavsky; Anupam B Jena
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.